Impact of dapagliflozin on metabolic phenotype, hormone levels, and fertility in female mice after prolonged high-fat diet
Xiaolin Chen, Zhuoni Xiao, Na Dai, Mingxia Fan · 2025
Read Impact of dapagliflozin on metabolic phenotype, hormone levels, and fertility in female mice after prolonged high-fat diet by Xiaolin Chen, Zhuoni Xiao, Na Dai, Mingxia Fan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11791800.txt.
Description
Xiaolin Chen and colleagues test a diabetes drug on fat-fed female mice to see if it can rescue fertility, in this study from twenty twenty-four. A long high-fat diet makes mice obese and can stop their eggs from maturing, through insulin resistance and inflammation in the brain. The drug, dapagliflozin, helps the kidneys shed sugar and is already used in diabetes care.
After sixteen weeks on the rich diet, treated mice gained less belly fat and handled sugar and insulin better. By thirty-two weeks those body benefits had faded. Yet the drug's help for reproduction lasted: treated mice kept healthier hormone patterns, with better release of a key fertility hormone, and bred more soundly. Blood markers of inflammation never moved, in either group. The authors read this as a direct route from the drug to the brain's fertility controls, apart from weight loss.
Catalog record
| CREATOR | Xiaolin Chen, Zhuoni Xiao, Na Dai, Mingxia Fan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |